OPPENHEIMER ASSET MANAGEMENT INC. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$3,768,259
-4.0%
243,585
-2.5%
0.06%0.0%
Q2 2023$3,923,729
-6.2%
249,760
-1.6%
0.06%
-9.4%
Q1 2023$4,183,942
+1.8%
253,880
-3.6%
0.06%
-3.0%
Q4 2022$4,109,320
+7.8%
263,418
-10.4%
0.07%
-1.5%
Q3 2022$3,812,000
-8.0%
293,966
-0.4%
0.07%
-2.9%
Q2 2022$4,142,000
-6.8%
295,010
-5.0%
0.07%
+9.5%
Q1 2022$4,445,000
+13.0%
310,450
+7.6%
0.06%
+21.2%
Q4 2021$3,933,000
-42.9%
288,524
-31.4%
0.05%
-46.9%
Q3 2021$6,889,000
-7.4%
420,517
-4.9%
0.10%
-7.5%
Q2 2021$7,439,000
+7.2%
442,007
+16.3%
0.11%
-1.9%
Q1 2021$6,937,000
+10.1%
379,903
+9.8%
0.11%
+2.9%
Q4 2020$6,298,000
+10.1%
346,045
+7.9%
0.10%
-5.4%
Q3 2020$5,722,000
-3.1%
320,743
-2.6%
0.11%
-9.0%
Q2 2020$5,903,000
-0.8%
329,221
-16.0%
0.12%
-16.4%
Q1 2020$5,949,000
-29.4%
391,888
-8.2%
0.15%
-18.0%
Q4 2019$8,421,000
+9.8%
426,802
-4.3%
0.18%
+4.7%
Q3 2019$7,669,000
-1.1%
445,849
+1.8%
0.17%
-0.6%
Q2 2019$7,754,000
-1.0%
438,024
+13.9%
0.17%
-2.8%
Q1 2019$7,830,000
+50.1%
384,408
+23.9%
0.18%
+36.4%
Q4 2018$5,217,000310,1610.13%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders